Balderton Capital raises new €530M early-stage fund; here’s what the VC plans to…
Balderton Capital is a venture capital firm focused exclusively on backing European-founded startups.
Where the capital lands, who writes the cheque, and what gets built with it. Funding rounds, venture capital flows, and the deal-making that shapes which technology companies scale.
6,921 articles · Funding
Balderton Capital is a venture capital firm focused exclusively on backing European-founded startups.
UXCam, an experience analytics platform for mobile apps, announced that it has secured $5M (approx €4.4M) in a Seed round led by Headline.
Sofinnova Partners is a venture capital firm in Europe with 50 years of experience backing over 500 companies.
Daedalus is currently working on its first autonomous factory for high-precision mechanical components and is already producing parts for customers in the automotive, machinery, and medical device industries.
Scope Biosciences specialises in the development of molecular diagnostics using CRISPR-Cas.
Kubermatic helps organisations automate their Kubernetes and cloud-native operations across multi-cloud, edge, and on-prem environments.
Hadrian, a cybersecurity startup based out of London and Amsterdam, announced that it has raised €2.5M pre-seed round to build the first…
London’s startup ecosystem is by far the largest in Europe with a total value of $142.7B.
Lyre's, a London-based producer of non-alcoholic spirits, announced that it has secured £20M (approx €23.6M) funding at a valuation of £270M (approx €319M), up from a valuation of £100M earlier this year.
French Healthtech startup Lifen, today, has announced that it has raised €50M funding in a Series C round led by Creadev and Lauxera Capital Partners, with participation from existing investors Partech and Serena.
Vianova, a Paris-based urban mobility management platform, announced that it has secured $3M (approx €2.6M) funding in the Seed round.
Nuritas, a Dublin-based biotechnology company that uses proprietary AI to discover plant-based bioactive peptides, announced that it has secured $45M (approx €39M) funding in the Series B round.